- Chemical name: 17α-Methyl-17β-hydroxy-[5α]-androst-2-eno[3,2-c]pyrazole
- Formula: C21H32N2O
- Anabolic activity index: 320%
- Androgenic activity index: 30%
STANOS – PHARMACOM LABS
100 tabs x 10 mg
Stanozolol, commonly known as Winstrol, is a 17-alpha-alkylated derivative of dihydrotestosterone (DHT) with notable anabolic and low androgenic qualities. Initially developed in 1962 by Sterling-Winthrop Laboratories, it was intended for increasing lymphocyte count and influencing immunological processes, particularly for treating autoimmune disorders and hereditary angioedema.
Benefits:
- Highly anabolic with low androgenic properties.
- Produced in tablet and injectable forms, both characterized by good bioavailability.
- Notable for its ability to provide a lean, quality look without water retention, making it ideal for cutting cycles.
- Preferred by athletes in strength/speed sports like track and field for its enhancing effects.
Side Effects:
- Does not convert into estradiol, eliminating the need for aromatase inhibitors.
- Exhibits a diuretic effect, preventing water retention and promoting a lean appearance.
- Possesses the ability to lower sex hormone-binding globulin (SHBG), increasing the efficiency of other steroids in a stack.
- Potential to increase tendon brittleness, caution advised to prevent joint pain and damage.
- Both tablet and injectable forms may impact cholesterol levels, necessitating monitoring of lipid profiles during cycles.
Dosage Instructions:
- Generally recommended for athletes with sufficient muscle bulk aiming to improve endurance and achieve increased muscle relief and hardness.
- Stacking with testosterone is advisable to counter the potential impact on sex hormone-binding globulin (SHBG) levels.
- Monitoring lipid profiles through blood works during the cycle is recommended to address potential adverse changes in cholesterol levels.
- Well-suited for cutting cycles, contributing to the elimination of excess subcutaneous water and fat while promoting well-defined muscularity.
